Modulating pain in the periphery: Gene-based therapies to enhance peripheral opioid analgesia: Bonica lecture, ASRA 2010

Regional Anesthesia and Pain Medicine

Volumn 37, Issue 2, 2012, Pages 210-214

  Raja, Srinivasa N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ADENO ASSOCIATED VIRUS; ANALGESIA; ARTICLE; CHRONIC PAIN; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HERPES SIMPLEX VIRUS; HUMAN; NERVE CELL PLASTICITY; NEUROPATHIC PAIN; NEUROPHYSIOLOGY; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; SIGNAL TRANSDUCTION; VIRAL GENE THERAPY;

ANALGESIA; ANALGESICS, OPIOID; ANESTHESIA, CONDUCTION; ANIMALS; AWARDS AND PRIZES; GENETIC THERAPY; HUMANS; NEURALGIA; PAIN MEASUREMENT; SOCIETIES, MEDICAL;

EID: 84859774496     PISSN: 10987339     EISSN: 15328651     Source Type: Journal    
DOI: 10.1097/AAP.0b013e31823b145f     Document Type: Article

References (56)

1. Meyer RA, Campbell JN. Myelinated nociceptive afferents account for the hyperalgesia that follows a burn to the hand. Science. 1981;4515:1527Y1529. (Pubitemid 11031242)
2. Raja SN, Meyer RA, Campbell JN. Peripheral mechanisms of somatic pain. Anesthesiology. 1988;4:571Y590.
3. Campbell JN, Raja SN, Meyer RA, Mackinnon SE. Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain. 1988;1:89Y94.
4. Davis KD, Treede RD, Raja SN, Meyer RA, Campbell JN. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain. 1991;3:309Y317.
5. Raja SN, Campbell JN, Meyer RA. Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin. Brain. 1984;107:1179Y1188. (Pubitemid 15182103)
6. Manning DC, Raja SN, Meyer RA, Campbell JN. Pain and hyperalgesia after intradermal injection of bradykinin in humans. Clin Pharmacol Ther. 1991;6:721Y729.
7. Raja SN, Campbell JN, Meyer RA, Colman RW. Role of kinins in pain and hyperalgesia: psychophysical studies in a patient with kininogen deficiency. Clin Sci (Lond). 1992;3:337Y341.
8. Treede RD, Meyer RA, Raja SN, Campbell JN. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol. 1992;4:397Y421.
9. Ma QP, Woolf CJ. Progressive tactile hypersensitivity: an inflammation-induced incremental increase in the excitability of the spinal cord. Pain. 1996;1:97Y106. (Pubitemid 26319641)
10. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983;5944:686Y688. (Pubitemid 14201852)
11. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;3(suppl):S2YS15.
12. Ali Z, Raja SN, Wesselmann U, Fuchs PN, Meyer RA, Campbell JN. Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain. Pain. 2000;2:161Y168.
13. Lin EE, Horasek S, Agarwal S, Wu CL, Raja SN. Local administration of norepinephrine in the stump evokes dose-dependent pain in amputees. Clin J Pain. 2006;5:482Y486. (Pubitemid 44350458)
14. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002;7:1015Y1021.
15. Wu CL, Agarwal S, Tella PK, et al. Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial. Anesthesiology. 2008;2:289Y296.
16. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med. 2003;13:1223Y1232. (Pubitemid 36359298)
17. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;6:1837Y1841. (Pubitemid 28283261)
18. Agarwal S, Polydefkis M, Block B, Haythornthwaite J, Raja SN. Transdermal fentanyl reduces pain and improves functional activity in neuropathic pain states. Pain Med. 2007;7:554Y562. (Pubitemid 47490211)
19. DuPont RL. Prescription drug abuse: an epidemic dilemma. J Psychoactive Drugs. 2010;2:127Y132.
20. Riggs P. Non-medical use and abuse of commonly prescribed medications. Curr Med Res Opin. 2008;3:869Y877. (Pubitemid 351428998)
21. Lewanowitsch T, Miller JH, Irvine RJ. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide. Life Sci. 2006;7:682Y688. (Pubitemid 41821124)
22. Obara I, Przewlocki R, Przewlocka B. Local peripheral effects of mu-opioid receptor agonists in neuropathic pain in rats. Neurosci Lett. 2004;1-2:85Y89. (Pubitemid 38471994)
23. Stein C, Schafer M, Machelska H. Attacking pain at its source: new perspectives on opioids. Nat Med. 2003;8:1003Y1008. (Pubitemid 37021779)
24. Coggeshall RE, Zhou S, Carlton SM. Opioid receptors on peripheral sensory axons. Brain Res. 1997;1-2:126Y132. (Pubitemid 27380647)
25. Truong W, Cheng C, Xu QG, Li XQ, Zochodne DW. mu opioid receptors and analgesia at the site of a peripheral nerve injury. Ann Neurol. 2003;3:366Y375. (Pubitemid 36258640)
26. Joseph EK, Levine JD. mu and delta opioid receptors on nociceptors attenuate mechanical hyperalgesia in rat. Neuroscience. 2010;1:344Y350.
27. Patapoutian A, Tate S, Woolf CJ. Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov. 2009;1:55Y68.
28. Argoff CE. Topical agents for the treatment of chronic pain. Curr Pain Headache Rep. 2006;1:11Y19.
29. Smith HS. Peripherally-acting opioids. Pain Physician. 2008;2(suppl):S121YS132. (Pubitemid 351682082)
30. Derry S, Lloyd R, Moore RA, McQuay HJ. Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2009;4:CD007393.
31. Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron. 2006;1:77Y92. (Pubitemid 44466361)
32. Jarvis MF, Boyce-Rustay JM. Neuropathic pain: models and mechanisms. Curr Pharm Des. 2009;15:1711Y1716.
33. Guan Y, Johanek LM, Hartke TV, et al. Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury. Pain. 2008;2:318Y329.
34. Lee CY, Perez FM, Wang W, et al. Dynamic temporal and spatial regulation of mu opioid receptor expression in primary afferent neurons following spinal nerve injury. Eur J Pain. 2011;7:669Y675.
35. Davidson BL, Breakefield XO. Viral vectors for gene delivery to the nervous system. Nat Rev Neurosci. 2003;5:353Y364. (Pubitemid 37280174)
36. Fink DJ, Wechuck J, Mata M, et al. Gene therapy for pain: results of a phase I clinical trial. Ann Neurol. 2011;2:207Y212.
37. Goss JR, Goins WF, Glorioso JC. Gene therapy applications for the treatment of neuropathic pain. Expert Rev Neurother. 2007;5:487Y506. (Pubitemid 46743442)
38. Wilson SP, Yeomans DC. Genetic therapy for pain management. Curr Rev Pain. 2000;6:445Y450.
39. Goss JR, Harley CF, Mata M, et al. Herpes vectorYmediated expression of proenkephalin reduces bone cancer pain. Ann Neurol. 2002;5:662Y665. (Pubitemid 35246874)
40. Hao S, Mata M, Goins W, Glorioso JC, Fink DJ. Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain. Pain. 2003;1-2:135Y142. (Pubitemid 36298869)
41. Hao S, Hu J, Fink DJ. Transgene-mediated enkephalin expression attenuates signs of naloxone-precipitated morphine withdrawal in rats with neuropathic pain. Behav Brain Res. 2009;1:84Y89.
42. Meunier A, Latremoliere A, Mauborgne A, et al. Attenuation of pain-related behavior in a rat model of trigeminal neuropathic pain by viral-driven enkephalin overproduction in trigeminal ganglion neurons. Mol Ther. 2005;4:608Y616. (Pubitemid 40353118)
43. Wilson SP, Yeomans DC, Bender MA, Lu Y, Goins WF, Glorioso JC. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci U S A. 1999;6:3211Y3216. (Pubitemid 29148870)
44. Yang H, McNearney TA, Chu R, et al. Enkephalin-encoding herpes simplex virus-1 decreases inflammation and hotplate sensitivity in a chronic pancreatitis model. Mol Pain. 2008;4:8.
45. Yeomans DC, Lu Y, Laurito CE, et al. Recombinant herpes vectorYmediated analgesia in a primate model of hyperalgesia. Mol Ther. 2006;3:589Y597. (Pubitemid 43257627)
46. Yokoyama H, Sasaki K, Franks ME, et al. Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Hum Gene Ther. 2009;1:63Y71.
47. Yoshimura N, Franks ME, Sasaki K, et al. Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE). Urology. 2001;6(suppl 1):116.
48. Glorioso JC, Fink DJ. Herpes vectorYmediated gene transfer in treatment of diseases of the nervous system. Annu Rev Microbiol. 2004;253Y271. (Pubitemid 39551987)
49. Palmer JA, Branston RH, Lilley CE, et al. Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system. J Virol. 2000;12:5604Y5618. (Pubitemid 30346595)
50. Wilson SP, Yeomans DC. Virally mediated delivery of enkephalin and other neuropeptide transgenes in experimental pain models. Ann N Y Acad Sci. 2002;971:515Y521. (Pubitemid 35305346)
51. Braz J, Beaufour C, Coutaux A, et al. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J Neurosci. 2001;20:7881Y7888. (Pubitemid 32952747)
52. Lu Y, McNearney TA, Wilson SP, Yeomans DC, Westlund KN. Joint capsule treatment with enkephalin-encoding HSV-1 recombinant vector reduces inflammatory damage and behavioural sequelae in rat CFA monoarthritis. Eur J Neurosci. 2008;5:1153Y1165. (Pubitemid 351432328)
53. Cabanero D, Celerier E, Garcia-Nogales P, et al. The pro-nociceptive effects of remifentanil or surgical injury in mice are associated with a decrease in delta-opioid receptor mRNA levels: Prevention of the nociceptive response by on-site delivery of enkephalins. Pain. 2009;1-2:88Y96.
54. Lu Y, McNearney TA, Lin W, Wilson SP, Yeomans DC, Westlund KN. Treatment of inflamed pancreas with enkephalin encoding HSV-1 recombinant vector reduces inflammatory damage and behavioral sequelae. Mol Ther. 2007;10:1812Y1819. (Pubitemid 47434188)
55. Zhang G, Mohammad H, Peper BD, Raja S, Wilson SP, Sweitzer SM. Enhanced peripheral analgesia using virally mediated gene transfer of the mu-opioid receptor in mice. Anesthesiology. 2008;2:305Y313. (Pubitemid 351156741)
56. Vadivelu N, Mitra S, Hines RL. Peripheral opioid receptor agonists for analgesia: a comprehensive review. J Opioid Manag. 2011;1:55Y68.